Advisory Committee on Breast Cancer in Young Women (ACBCYW), 79592-79593 [2015-32015]

Download as PDF 79592 Federal Register / Vol. 80, No. 245 / Tuesday, December 22, 2015 / Notices the four training models, and training and technical assistance instructors, coaches and subject matter experts. CDC will use the information collected to evaluate the effectiveness of the Work@Health® Program in terms of (1) increasing employer’s knowledge and awareness of worksite health concepts, principles, and resources, and (2) increasing the number of sciencebased worksite health programs, policies and practices in place at participating employers’ worksites. The information will also be used to continue to identify and improve the best way(s) to deliver skill-based training and technical support to employers in the area of worksite health. OMB approval is requested for three years. Participation in Work@Health® is voluntary and there are no costs to participants other than their time. The total estimated annualized burden hours are 1,047. ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per respondent Form name Interested Employer ................ Employers Participating in Work@Health. Employer Application Form .................................................... CDC Worksite Health Scorecard ........................................... Organizational Assessment .................................................... Employer Follow-up Survey ................................................... Case Study Interviews with Senior Leadership ..................... Case Study Interviews with Employees ................................. Trainee KAB Survey ............................................................... Trainee Reaction Survey—Hands-On Model ......................... Trainee Reaction Survey—Online Model ............................... Trainee Reaction Survey—Blended Model ............................ Trainee Technical Assistance Survey .................................... Case Study Interviews with Selected Trainees ..................... Trainee Focus Group Discussion Guide ................................ Train-the-Trainer Application Form ........................................ 400 320 320 160 2 4 640 100 120 100 640 10 7 80 1 1 1 1 1 1 1 1 1 1 1 1 1 1 20/60 0.5 15/60 15/60 1 1 20/60 15/60 15/60 15/60 15/60 1 1.5 0.5 Train-the-Trainer Participant Survey ...................................... Trainee Reaction Survey—Train-the-Trainer Model .............. Train-the-Trainer Trainee Technical Assistance Survey ........ Wave 2 Trainee Reaction Survey .......................................... 80 40 80 200 1 1 1 1 20/60 15/60 15/60 15/60 Instructor/Coach Group Discussion Guide ............................. 7 1 0.5 Trainees Participating in the Work@Health Program (Hands-on, Online, Blended models). Interested Train-the-Trainer Participants. Trainees Participating in the Work@Health Program (Train-the-Trainer model). Trainees participating in the Work@Health Program Wave 2. Work@Health Instructors/ Coaches. Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2015–32139 Filed 12–21–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention mstockstill on DSK4VPTVN1PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) DP 16–001, Pregnancy Risk Assessment Monitoring System (PRAMS). VerDate Sep<11>2014 17:21 Dec 21, 2015 Jkt 238001 Number of respondents Average burden per response (in hrs.) Type of respondent Time and Date: 11:00 a.m.–6:00 p.m., EST, Panel C, February 3, 2016 (Closed) Place: Teleconference Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘FOA DP16–001, Panel C, Pregnancy Risk Assessment Monitoring System (PRAMS)’’. Contact Person for More Information: Jayalakshmi Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488– 6511, kva5@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–32017 Filed 12–21–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Breast Cancer in Young Women (ACBCYW) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 9:30 a.m.–4:00 p.m. EST, January 28, 2016; 9:30 a.m.–3:00 p.m. EST, January 29, 2016. E:\FR\FM\22DEN1.SGM 22DEN1 mstockstill on DSK4VPTVN1PROD with NOTICES Federal Register / Vol. 80, No. 245 / Tuesday, December 22, 2015 / Notices Place: CDC, 4770 Buford Highway, Chamblee Building 106 1A/1B, Atlanta, Georgia 30341. This meeting is also accessible by teleconference and web access. Teleconference and web access login information are as follows: Toll-Free Telephone: 1–888–972–9241, Participant passcode: 8025509. Net Conference and Web Url: For January 28, 2016: https://www.my meetings.com/nc/join/. Conference number: PW6371280, Audience passcode: 8025509. Participants can join the event directly at: https://www.mymeetings.com/nc/join.php?i= PW6371280&p=8025509&t=c. For January 29, 2016: https://www.my meetings.com/nc/join/. Conference number: PW6371295, Audience passcode: 8025509. Participants can join the event directly at: https://www.mymeetings.com/nc/join.php?i= PW6371295&p=8025509&t=c. Status: Open to the public, limited only by the space and audio phone lines available. Purpose: The committee provides advice and guidance to the Secretary, HHS; the Assistant Secretary for Health; and the Director, CDC, regarding the formative research, development, implementation and evaluation of evidence-based activities designed to prevent breast cancer (particularly among those at heightened risk) and promote the early detection and support of young women who develop the disease. The advice provided by the Committee will assist in ensuring scientific quality, timeliness, utility, and dissemination of credible appropriate messages and resource materials. Matters for Discussion: The agenda will include discussions on the current and emerging topics related to breast cancer in young women. These will include public health communication, breast cancer in young women digital and social media campaigns, and CDC updates. Topics will address efforts to increase awareness around breast cancer risk, breast health, symptoms, diagnosis, and treatment of breast cancer in young women. Agenda items are subject to change as priorities dictate. Online Registration Required: In order to expedite the security clearance process required for entry into a Federal building, all ACBCYW attendees must register for the meeting online at least 7 business days in advance at https://www.cdc.gov/cancer/ breast/what_cdc_is_doing/meetings.htm. Please complete all the required fields before submitting your registration and submit no later than January 19, 2016. Each meeting day, attendees must provide CDC staff and security with driver’s license/state issued ID, or passport. Contact Person For More Information: Temeika L. Fairley, Ph.D., Designated Federal Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 5770 Buford Hwy. NE., Mailstop K52, Atlanta, Georgia 30341, Telephone (770) 488–4518, Fax (770) 488–4760. Email: acbcyw@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the VerDate Sep<11>2014 19:09 Dec 21, 2015 Jkt 238001 79593 authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Agency Information Collection Activities: Proposed Collection: Public Comment Request [FR Doc. 2015–32015 Filed 12–21–15; 8:45 am] BILLING CODE 4163–18–P Health Resources and Services Administration Health Resources and Services Administration, HHS. ACTION: Notice. AGENCY: In compliance with the requirement for opportunity for public comment on proposed data collection projects (Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995), the Health Resources and Services Administration (HRSA) announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR. DATES: Comments on this Information Collection Request must be received no later than February 19, 2016. ADDRESSES: Submit your comments to paperwork@hrsa.gov or mail the HRSA Information Collection Clearance Officer, Room 10–29, Parklawn Building, 5600 Fishers Lane, Rockville, MD 20857. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the data collection plans and draft instruments, email paperwork@hrsa.gov or call the HRSA Information Collection Clearance Officer at (301) 443–1984. SUPPLEMENTARY INFORMATION: When submitting comments or requesting information, please include the information request collection title for reference. SUMMARY: DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC) This notice was published in the Federal Register on December 14, 2015, Volume 80, Number 239, Page 77352. The Dial-in number should read as follows to include additional lines for public participation and to provide for people with disabilities: Teleconference Dial-In Number: 1– 888–469–1243, Participant Code: 4709506 TTY Accessible link: https://www. captionedtext.com/client/event.aspx? CustomerID=1891&EventID=2812715 CDC encourages participation by persons with disabilities. Captions and participation by persons with communications challenges will be available online via Relay Conference Captioning. To view the online captions at the start time of the event, please login for captioning at: https://www. captionedtext.com/client/event.aspx? CustomerID=1891&EventID=2812715. Contact Person For More Information: Arlene Greenspan, DrPH, M.P.H., P.T. Associate Director for Science, NCIPC, CDC, 4770 Buford Highway NE., Mailstop F–63, Atlanta, GA 30341, Telephone (770) 488–4696. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. AMENDMENT: Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–32016 Filed 12–21–15; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Information Collection Request Title: HRSA National Environmental Policy Act (NEPA) Environmental Information and Documentation (EID) OMB No. 0915–0324—Extension Abstract: HRSA is requesting extension of the approval for the Environmental Information and Documentation (EID) checklist which consists of information that the agency is required to obtain to comply with the National Environmental Policy Act of 1969 (NEPA). NEPA establishes the federal government’s national policy for protection of the environment. HRSA has developed the EID for applicants of funding that would potentially impact the environment and to ensure that their E:\FR\FM\22DEN1.SGM 22DEN1

Agencies

[Federal Register Volume 80, Number 245 (Tuesday, December 22, 2015)]
[Notices]
[Pages 79592-79593]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32015]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Breast Cancer in Young Women (ACBCYW)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

    Times and Dates: 9:30 a.m.-4:00 p.m. EST, January 28, 2016; 9:30 
a.m.-3:00 p.m. EST, January 29, 2016.

[[Page 79593]]

    Place: CDC, 4770 Buford Highway, Chamblee Building 106 1A/1B, 
Atlanta, Georgia 30341.
    This meeting is also accessible by teleconference and web 
access. Teleconference and web access login information are as 
follows:
    Toll-Free Telephone: 1-888-972-9241, Participant passcode: 
8025509.
    Net Conference and Web Url:
    For January 28, 2016: https://www.mymeetings.com/nc/join/.
    Conference number: PW6371280, Audience passcode: 8025509.
    Participants can join the event directly at: https://www.mymeetings.com/nc/join.php?i=PW6371280&p=8025509&t=c.
    For January 29, 2016: https://www.mymeetings.com/nc/join/.
    Conference number: PW6371295, Audience passcode: 8025509.
    Participants can join the event directly at: https://www.mymeetings.com/nc/join.php?i=PW6371295&p=8025509&t=c.
    Status: Open to the public, limited only by the space and audio 
phone lines available.
    Purpose: The committee provides advice and guidance to the 
Secretary, HHS; the Assistant Secretary for Health; and the 
Director, CDC, regarding the formative research, development, 
implementation and evaluation of evidence-based activities designed 
to prevent breast cancer (particularly among those at heightened 
risk) and promote the early detection and support of young women who 
develop the disease. The advice provided by the Committee will 
assist in ensuring scientific quality, timeliness, utility, and 
dissemination of credible appropriate messages and resource 
materials.
    Matters for Discussion: The agenda will include discussions on 
the current and emerging topics related to breast cancer in young 
women. These will include public health communication, breast cancer 
in young women digital and social media campaigns, and CDC updates. 
Topics will address efforts to increase awareness around breast 
cancer risk, breast health, symptoms, diagnosis, and treatment of 
breast cancer in young women.
    Agenda items are subject to change as priorities dictate.
    Online Registration Required: In order to expedite the security 
clearance process required for entry into a Federal building, all 
ACBCYW attendees must register for the meeting online at least 7 
business days in advance at https://www.cdc.gov/cancer/breast/what_cdc_is_doing/meetings.htm. Please complete all the required 
fields before submitting your registration and submit no later than 
January 19, 2016. Each meeting day, attendees must provide CDC staff 
and security with driver's license/state issued ID, or passport.
    Contact Person For More Information: Temeika L. Fairley, Ph.D., 
Designated Federal Officer, National Center for Chronic Disease 
Prevention and Health Promotion, CDC, 5770 Buford Hwy. NE., Mailstop 
K52, Atlanta, Georgia 30341, Telephone (770) 488-4518, Fax (770) 
488-4760. Email: acbcyw@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention, 
and Agency for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-32015 Filed 12-21-15; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.